Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Malignant Lymphoma

Free Subscription Articles published in Bone Marrow Transplant Retrieve available abstracts of 69 articles: HTML format

Single Articles

April 2008
1. JOHNSTON PB , Wiseman GA, Micallef IN
   Positron emission tomography using F-18 fluorodeoxyglucose pre- and post-autologous stem cell transplant in non-Hodgkin's lymphoma.
   Bone Marrow Transplant. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
2. NYMAN H , Jantunen E, Juvonen E, Elonen E, et al
   Impact of germinal center and non-germinal center phenotypes on overall and failure-free survival after high-dose chemotherapy and auto-SCT in primary diffuse large B-cell lymphoma.
   Bone Marrow Transplant. 2008;.
   PubMed     Related articles    Abstract available
   
   
   March 2008
3. YONEKURA K , Utsunomiya A, Takatsuka Y, Takeuchi S, et al
   Graft-versus-adult T-cell leukemia/lymphoma effect following allogeneic hematopoietic stem cell transplantation.
   Bone Marrow Transplant. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
4. SESHADRI T , Pintilie M, Keating A, Crump M, et al
   The relationship between absolute lymphocyte count with PFS in patients with Hodgkin's lymphoma undergoing autologous hematopoietic cell transplant.
   Bone Marrow Transplant. 2008;.
   PubMed     Related articles    Abstract available
   
   
   January 2008
5. THOMSON KJ , Peggs KS, Smith P, Cavet J, et al
   Superiority of reduced-intensity allogeneic transplantation over conventional treatment for relapse of Hodgkin's lymphoma following autologous stem cell transplantation.
   Bone Marrow Transplant. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
6. DUARTE RF , Schmitz N, Servitje O, Sureda A, et al
   Haematopoietic stem cell transplantation for patients with primary cutaneous T-cell lymphoma.
   Bone Marrow Transplant. 2008;.
   PubMed     Related articles    Abstract available
   
   
   December 2007
7. BRADLEY MB , Cairo MS
   Stem cell transplantation for pediatric lymphoma: past, present and future.
   Bone Marrow Transplant. 2007;.
   PubMed     Related articles    Abstract available
   
   
   
8. YAMAMOTO R , Takaori-Kondo A, Kanda J, Imada K, et al
   Durable remission of large B-cell lymphoma transformed from lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia successfully treated with sequential immunochemotherapy followed by reduced-intensity allogeneic stem cell transplantation.
   Bone Marrow Transplant. 2007;.
   PubMed     Related articles   
   
   
   
9. BENEKLI M , Smiley SL, Younis T, Czuczman MS, et al
   Intensive conditioning regimen of etoposide (VP-16), cyclophosphamide and carmustine (VCB) followed by autologous hematopoietic stem cell transplantation for relapsed and refractory Hodgkin's lymphoma.
   Bone Marrow Transplant. 2007;.
   PubMed     Related articles    Abstract available
   
   
   November 2007
10. SHIMONI A , Zwas ST, Oksman Y, Hardan I, et al
    Ibritumomab tiuxetan (Zevalin) combined with reduced-intensity conditioning and allogeneic stem-cell transplantation (SCT) in patients with chemorefractory non-Hodgkin's lymphoma.
    Bone Marrow Transplant. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
11. CALANDRA G , McCarty J, McGuirk J, Tricot G, et al
    AMD3100 plus G-CSF can successfully mobilize CD34+ cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: compassionate use data.
    Bone Marrow Transplant. 2007;.
    PubMed     Related articles    Abstract available
    
    
    October 2007
12. PHAM RN , Gooley TA, Keeney GE, Press OW, et al
    The impact of histologic grade on the outcome of high-dose therapy and autologous stem cell transplantation for follicular lymphoma.
    Bone Marrow Transplant. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
13. GISSELBRECHT C , Bethge W, Duarte RF, Gianni AM, et al
    Current status and future perspectives for yttrium-90 ((90)Y)-ibritumomab tiuxetan in stem cell transplantation for non-Hodgkin's lymphoma.
    Bone Marrow Transplant. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
14. MAGAGNOLI M , Spina M, Balzarotti M, Timofeeva I, et al
    IGEV regimen and a fixed dose of lenograstim: an effective mobilization regimen in pretreated Hodgkin's lymphoma patients.
    Bone Marrow Transplant. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
15. ELMAAGACLI AH , Koldehoff M, Steckel NK, Trenschel R, et al
    Cytochrome P450 2C19 loss-of-function polymorphism is associated with an increased treatment-related mortality in patients undergoing allogeneic transplantation.
    Bone Marrow Transplant. 2007;40:659-64.
    PubMed     Related articles    Abstract available
    
    
    
16. NATH CE , Shaw PJ, Trotman J, Zeng L, et al
    Pharmacokinetics of melphalan in myeloma patients undergoing an autograft.
    Bone Marrow Transplant. 2007;40:707-8.
    PubMed     Related articles   
    
    
    
17. KAMBLE RT , Bollard C, Demmler G, LaSala PR, et al
    Human metapneumovirus infection in a hematopoietic transplant recipient.
    Bone Marrow Transplant. 2007;40:699-700.
    PubMed     Related articles   
    
    
    September 2007
18. KANG TY , Rybicki LA, Bolwell BJ, Thakkar SG, et al
    Effect of prior rituximab on high-dose therapy and autologous stem cell transplantation in follicular lymphoma.
    Bone Marrow Transplant. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
19. KIM JG , Sohn SK, Chae YS, Yang DH, et al
    Multicenter study of intravenous busulfan, cyclophosphamide, and etoposide (i.v. Bu/Cy/E) as conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin's lymphoma.
    Bone Marrow Transplant. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
20. ARBER C , Buser A, Heim D, Weisser M, et al
    Septic polyarthritis with Ureaplasma urealyticum in a patient with prolonged agammaglobulinemia and B-cell aplasia after allogeneic HSCT and rituximab pretreatment.
    Bone Marrow Transplant. 2007;40:597-8.
    PubMed     Related articles   
    
    
    August 2007
21. ABDUL-HAI A , Weiss L, Ben-Yehuda A, Ergas D, et al
    Interleukin-7 induced facilitation of immunological reconstitution of sublethally irradiated mice following treatment with alloreactive spleen cells in a murine model of B-cell leukemia/lymphoma (BCL(1)).
    Bone Marrow Transplant. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
22. CHONABAYASHI K , Kondo T, Tanaka Y, Ichinohe T, et al
    Sustained complete remission of refractory enteropathy-type T-cell lymphoma following reduced-intensity unrelated cord blood transplantation.
    Bone Marrow Transplant. 2007;.
    PubMed     Related articles   
    
    
    
23. TIWARI D , Gao F, Hidalgo J, Adkins DR, et al
    Prognostic significance of early lymphocyte recovery after post-autografting administration of GM-CSF in non-Hodgkin's lymphoma.
    Bone Marrow Transplant. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
24. HERBERT KE , True S, McArthur G, Prince HM, et al
    Safety and efficacy of combining ATRA with G-CSF in HSPC mobilization; a pilot study in multiple myeloma and non-Hodgkin's lymphoma patients.
    Bone Marrow Transplant. 2007;.
    PubMed     Related articles   
    
    
    July 2007
25. AKHTAR S , El Weshi A, Abdelsalam M, Hussaini H, et al
    Primary refractory Hodgkin's lymphoma: outcome after high-dose chemotherapy and autologous SCT and impact of various prognostic factors on overall and event-free survival. A single institution result of 66 patients.
    Bone Marrow Transplant. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
26. BARKHOLT L , Remberger M, Bodegard H, Ringden O, et al
    Cyclosporine A (CsA) 2-h concentrations vary between patients without correlation to graft-versus-host disease after allogeneic haematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
27. MACLEAN PS , Parker AN, McQuaker IG, Clark AD, et al
    Ideal body weight correlates better with engraftment after PBSC autograft than actual body weight, but is under-estimated in myeloma patients possibly due to disease-related height loss.
    Bone Marrow Transplant. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
28. PICCIRILLO N , De Matteis S, De Vita S, Laurenti L, et al
    Kinetics of peg-filgrastim after high-dose chemotherapy and autologous peripheral blood stem cell transplantation.
    Bone Marrow Transplant. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
29. BOLWELL BJ , Pohlman B, Rybicki L, Sobecks R, et al
    Patients mobilizing large numbers of CD34+ cells ('super mobilizers') have improved survival in autologous stem cell transplantation for lymphoid malignancies.
    Bone Marrow Transplant. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
30. PILLAI A , Teo P, George T, Mukhopadhyay A, et al
    Alloantigen recognition is critical for CD8 T cell-mediated graft anti-tumor activity against murine BCL1 lymphoma after myeloablative bone marrow transplantation.
    Bone Marrow Transplant. 2007;.
    PubMed     Related articles    Abstract available
    
    
    June 2007
31. GABRIEL IH , Olavarria E, Jones RR, Whittaker S, et al
    Graft versus lymphoma effect after early relapse following reduced-intensity sibling allogeneic stem cell transplantation for relapsed cytotoxic variant of mycosis fungoides.
    Bone Marrow Transplant. 2007;.
    PubMed     Related articles   
    
    
    
32. FERNANDEZ HF , Escalon MP, Pereira D, Lazarus HM, et al
    Autotransplant conditioning regimens for aggressive lymphoma: are we on the right road?
    Bone Marrow Transplant. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
33. FEYLER S , Prince HM, Pearce R, Towlson K, et al
    The role of high-dose therapy and stem cell rescue in the management of T-cell malignant lymphomas: a BSBMT and ABMTRR study.
    Bone Marrow Transplant. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
34. VEERAPPAN R , Morrison M, Williams S, Variakojis D, et al
    Splenic rupture in a patient with plasma cell myeloma following G-CSF/GM-CSF administration for stem cell transplantation and review of the literature.
    Bone Marrow Transplant. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
35. LEVENGA H , Levison-Keating S, Schattenberg AV, Dolstra H, et al
    Multiple myeloma patients receiving pre-emptive donor lymphocyte infusion after partial T-cell-depleted allogeneic stem cell transplantation show a long progression-free survival.
    Bone Marrow Transplant. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
36. VAN DER VELDEN AM , Claessen AM, van Velzen-Blad H, Biesma DH, et al
    Development of T cell-mediated immunity after autologous stem cell transplantation: prolonged impairment of antigen-stimulated production of gamma-interferon.
    Bone Marrow Transplant. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
37. MEEHAN KR , Wu J, Bengtson E, Hill J, et al
    Early recovery of aggressive cytotoxic cells and improved immune resurgence with post-transplant immunotherapy for multiple myeloma.
    Bone Marrow Transplant. 2007;39:695-703.
    PubMed     Related articles    Abstract available
    
    
    
38. KHALED Y , Kato K, Janakiraman N, Ferrara JL, et al
    Early relapses do not impact survival after autologous stem cell transplantation in African Americans with multiple myeloma.
    Bone Marrow Transplant. 2007;39:727-8.
    PubMed     Related articles   
    
    
    
39. FRUEHAUF S , Klaus J, Huesing J, Veldwijk MR, et al
    Efficient mobilization of peripheral blood stem cells following CAD chemotherapy and a single dose of pegylated G-CSF in patients with multiple myeloma.
    Bone Marrow Transplant. 2007;39:743-50.
    PubMed     Related articles    Abstract available
    
    
    
40. ANDERSON KO , Giralt SA, Mendoza TR, Brown JO, et al
    Symptom burden in patients undergoing autologous stem-cell transplantation.
    Bone Marrow Transplant. 2007;39:759-66.
    PubMed     Related articles    Abstract available
    
    
    May 2007
41. TOMBLYN M , Burns LJ, Blazar B, Wagner J, et al
    Difficult stem cell mobilization despite adequate CD34(+) cell dose predicts shortened progression free and overall survival after autologous HSCT for lymphoma.
    Bone Marrow Transplant. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
42. SMITH SD , Bolwell BJ, Rybicki LA, Brown S, et al
    Autologous hematopoietic stem cell transplantation in peripheral T-cell lymphoma using a uniform high-dose regimen.
    Bone Marrow Transplant. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
43. DIGNAN F , Gujral D, Ethell M, Evans S, et al
    Prophylactic defibrotide in allogeneic stem cell transplantation: minimal morbidity and zero mortality from veno-occlusive disease.
    Bone Marrow Transplant. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
44. KEW AK , Macaulay R, Burrell S, Rubin S, et al
    Central nervous system graft-versus-host disease presenting with granulomatous encephalitis.
    Bone Marrow Transplant. 2007;.
    PubMed     Related articles   
    
    
    
45. MOSKOWITZ A , Nolan C, Lis E, Castro-Malaspina H, et al
    Posterior reversible encephalopathy syndrome due to sirolimus.
    Bone Marrow Transplant. 2007;39:653-4.
    PubMed     Related articles   
    
    
    
46. GERTZ MA , Lacy MQ, Dispenzieri A, Hayman SR, et al
    Impact of age and serum creatinine value on outcome after autologous blood stem cell transplantation for patients with multiple myeloma.
    Bone Marrow Transplant. 2007;39:605-11.
    PubMed     Related articles    Abstract available
    
    
    April 2007
47. SCHMIDT-HIEBER M , Blau IW, Trenschel R, Andreesen R, et al
    Reduced-toxicity conditioning with fludarabine and treosulfan prior to allogeneic stem cell transplantation in multiple myeloma.
    Bone Marrow Transplant. 2007;39:389-96.
    PubMed     Related articles    Abstract available
    
    
    March 2007
48. KAMEZAKI K , Kikushige Y, Numata A, Miyamoto T, et al
    Rituximab does not compromise the mobilization and engraftment of autologous peripheral blood stem cells in diffuse-large B-cell lymphoma.
    Bone Marrow Transplant. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
49. OHWADA C , Nakaseko C, Tanaka H, Abe D, et al
    Successful matched unrelated BMT for secondary AML which developed simultaneously with relapsed Hodgkin's lymphoma.
    Bone Marrow Transplant. 2007;.
    PubMed     Related articles   
    
    
    
50. ISHIGURO H , Yasuda Y, Tomita Y, Shinagawa T, et al
    Gonadal shielding to irradiation is effective in protecting testicular growth and function in long-term survivors of bone marrow transplantation during childhood or adolescence.
    Bone Marrow Transplant. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
51. BUSER AS , Stern M, Bucher C, Arber C, et al
    High-dose chemotherapy using BEAM without autologous rescue followed by reduced-intensity conditioning allogeneic stem-cell transplantation for refractory or relapsing lymphomas: a comparison of delayed versus immediate transplantation.
    Bone Marrow Transplant. 2007;39:335-40.
    PubMed     Related articles    Abstract available
    
    
    February 2007
52. MACHINO T , Okoshi Y, Kaneko S, Obara N, et al
    Hepatosplenic alphabeta T-cell lymphoma successfully treated with allogeneic bone marrow transplantation.
    Bone Marrow Transplant. 2007;.
    PubMed     Related articles   
    
    
    January 2007
53. QAZILBASH MH , Saliba RM, Hosing C, Mendoza F, et al
    Autologous stem cell transplantation is safe and feasible in elderly patients with multiple myeloma.
    Bone Marrow Transplant. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
54. HILGENDORF I , Casper J, Sviland L, Prall F, et al
    Toxic epidermal necrolysis after allogeneic haematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2007;.
    PubMed     Related articles   
    
    
    
55. SUBRAMANIAM K , George B, Mathews V, Viswabandya A, et al
    Salvage with a mini-allograft after primary engraftment failure following autologous transplant for multiple myeloma.
    Bone Marrow Transplant. 2007;.
    PubMed     Related articles   
    
    
    
56. SIROHI B , Powles R, Morgan G, Treleaven J, et al
    Use of physiological doses of human growth hormone in haematological patients receiving intensive chemotherapy promotes haematopoietic recovery: a double-blind randomized, placebo-controlled study.
    Bone Marrow Transplant. 2007;39:115-20.
    PubMed     Related articles    Abstract available
    
    
    December 2006
57. HAKE CR , Graubert TA, Fenske TS
    Does autologous transplantation directly increase the risk of secondary leukemia in lymphoma patients?
    Bone Marrow Transplant. 2006;.
    PubMed     Related articles    Abstract available
    
    
    November 2006
58. PERZ JB , Giles C, Szydlo R, O'shea D, et al
    LACE-conditioned autologous stem cell transplantation for relapsed or refractory Hodgkin's lymphoma: treatment outcome and risk factor analysis in 67 patients from a single centre.
    Bone Marrow Transplant. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
59. KAMBLE RT , Chang CC, Sanchez S, Carrum G, et al
    Central nervous system graft-versus-host disease: report of two cases and literature review.
    Bone Marrow Transplant. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
60. KLEPIN HD , Hurd DD
    Autologous transplantation in elderly patients with multiple myeloma: are we asking the right questions?
    Bone Marrow Transplant. 2006;38:585-92.
    PubMed     Related articles    Abstract available
    
    
    
61. MORI T , Aisa Y, Yamazaki R, Mihara A, et al
    Cryotherapy for the prevention of high-dose melphalan-induced oral mucositis.
    Bone Marrow Transplant. 2006;38:637-8.
    PubMed     Related articles   
    
    
    October 2006
62. PEREZ-PERSONA E , Mateos-Mazon JJ, Lopez-Villar O, Arcos MJ, et al
    Complete remission of subcutaneous panniculitic T-cell lymphoma after allogeneic transplantation.
    Bone Marrow Transplant. 2006;.
    PubMed     Related articles   
    
    
    
63. JANTUNEN E
    Autologous stem cell transplantation beyond 60 years of age.
    Bone Marrow Transplant. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
64. GRAZZIUTTI ML , Dong L, Miceli MH, Krishna SG, et al
    Oral mucositis in myeloma patients undergoing melphalan-based autologous stem cell transplantation: incidence, risk factors and a severity predictive model.
    Bone Marrow Transplant. 2006;38:501-6.
    PubMed     Related articles    Abstract available
    
    
    September 2006
65. ARMITAGE AE , Armitage JD, Armitage JO
    Alpha-interferon for relapsed non-Hodgkin's lymphoma.
    Bone Marrow Transplant. 2006;.
    PubMed     Related articles   
    
    
    
66. PARKINS MD , Bahlis N, Brown C, Savoie L, et al
    Overnight storage of autologous stem cell apheresis products before cryopreservation does not adversely impact early or long-term engraftment following transplantation.
    Bone Marrow Transplant. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
67. MOLLE I , Peterslund NA, Thiel S, Steffensen R, et al
    MBL2 polymorphism and risk of severe infections in multiple myeloma patients receiving high-dose melphalan and autologous stem cell transplantation.
    Bone Marrow Transplant. 2006;.
    PubMed     Related articles    Abstract available
    
    
    August 2006
68. QUITTET P , Ceballos P, Lopez E, Lu ZY, et al
    Low doses of GM-CSF (molgramostim) and G-CSF (filgrastim) after cyclophosphamide (4 g/m2) enhance the peripheral blood progenitor cell harvest: results of two randomized studies including 120 patients.
    Bone Marrow Transplant. 2006;38:275-84.
    PubMed     Related articles    Abstract available
    
    
    
69. KUSUMI E , Yuji K, Kishi A, Murashige N, et al
    Molluscum contagiosum infection after reduced-intensity cord blood transplantation.
    Bone Marrow Transplant. 2006;38:313-4.
    PubMed     Related articles   
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: